Income, race, and cardiovascular disease in female breast cancer survivors: evidence of moderated socioeconomic protection in the National Health Interview Survey (NHIS) 2019–2022

Cardiovascular disease (CVD) remains a leading cause of poor outcomes among breast cancer survivors. Treatment contributes to both acute and long-term CVD risk, but social determinants of health (SDoH), like economic deprivation, also compound vulnerability. This study examined the associations between poverty-to-income ratio (PIR) and self-reported CVD in a national sample of breast cancer survivors. METHODS: Using National Health Interview Survey (NHIS) data from 2019 to 2022, we examined sociodemographic characteristics, health behaviors, and comorbidities in a sample of 2745 female breast cancer survivors. We tested IPTW-adjusted logistic models for associations between PIR and CVD prevalence and interactions by race, age, years of survivorship, and delayed medical care. RESULTS: Higher income did not protect survivors equally. The protection of higher PIR was significantly modified by race/ethnicity (p < 0.0001). Higher PIR reduced the odds of CVD 92% among Black survivors, compared to 68% among White survivors, with no significant association among Asian survivors. The protection of higher PIR was greatest among survivors aged < 65 years and lessened progressively up to ≥ 85 years (p = 0.017). The overall interaction terms were non-significant (p > 0.05) for years of breast cancer survivorship and approached significance for delayed care-seeking. CONCLUSIONS: PIR emerged as a robust predictor of comorbid CVD with strongest protection among younger, racial/ethnic minority, and early-survivorship subgroups. IMPLICATIONS FOR CANCER SURVIVORS: Clinical CVD risk models in breast cancer remain underspecified when measures of economic status are excluded. These findings support extending clinical guidance for CVD prevention beyond the current 5-year threshold and integrating economic screening into survivorship care.

Authors

Institutions

Publication Details

Journal
Journal of Cancer Survivorship
Published
2026-09-04
DOI
https://doi.org/10.1007/s11764-026-02112-3
Primary Topic
Chemotherapy-induced cardiotoxicity and mitigation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Income, race, and cardiovascular disease in female breast cancer survivors: evidence of moderated socioeconomic protection in the National Health Interview Survey (NHIS) 2019–2022

Robina Josiah Willock, Chaohua Li, Phillip Levy, Desiree Rivers et al.
Journal of Cancer Survivorship
Chemotherapy-induced cardiotoxicity and mitigation
article

Income, race, and cardiovascular disease in female breast cancer survivors: evidence of moderated socioeconomic protection in the National Health Interview Survey (NHIS) 2019–2022

Robina Josiah Willock, Chaohua Li, Phillip Levy, Desiree Rivers, Daniel Parks, Samah Nabi, Brian Rivers
article en

Abstract

Cardiovascular disease (CVD) remains a leading cause of poor outcomes among breast cancer survivors. Treatment contributes to both acute and long-term CVD risk, but social determinants of health (SDoH), like economic deprivation, also compound vulnerability. This study examined the associations between poverty-to-income ratio (PIR) and self-reported CVD in a national sample of breast cancer survivors. METHODS: Using National Health Interview Survey (NHIS) data from 2019 to 2022, we examined sociodemographic characteristics, health behaviors, and comorbidities in a sample of 2745 female breast cancer survivors. We tested IPTW-adjusted logistic models for associations between PIR and CVD prevalence and interactions by race, age, years of survivorship, and delayed medical care. RESULTS: Higher income did not protect survivors equally. The protection of higher PIR was significantly modified by race/ethnicity (p < 0.0001). Higher PIR reduced the odds of CVD 92% among Black survivors, compared to 68% among White survivors, with no significant association among Asian survivors. The protection of higher PIR was greatest among survivors aged < 65 years and lessened progressively up to ≥ 85 years (p = 0.017). The overall interaction terms were non-significant (p > 0.05) for years of breast cancer survivorship and approached significance for delayed care-seeking. CONCLUSIONS: PIR emerged as a robust predictor of comorbid CVD with strongest protection among younger, racial/ethnic minority, and early-survivorship subgroups. IMPLICATIONS FOR CANCER SURVIVORS: Clinical CVD risk models in breast cancer remain underspecified when measures of economic status are excluded. These findings support extending clinical guidance for CVD prevention beyond the current 5-year threshold and integrating economic screening into survivorship care.

Journal of Cancer Survivorship
Wayne State University (US), Morehouse School of Medicine (US)
Health Equity Research Center, Washington State University
No poverty
Openalex Percentile: Top 11%
Chemotherapy-induced cardiotoxicity and mitigation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.